Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15053270 | 1.00 | ACACB (0.81) | ACACBACACA | |
| SCHEMBL9932212 | 0.92 | ACACB (0.80) | ACACB | |
| SCHEMBL9932214 | 0.92 | ACACB (0.80) | ACACB | |
| SCHEMBL9966965 | 0.91 | ACACB (0.68) | ACACB | |
| SCHEMBL9966763 | 0.90 | ACACB (0.71) | ACACBACACA | |
| SCHEMBL15083880 | 0.90 | ACACB (1.00) | ACACB | |
| SCHEMBL9966769 | 0.88 | ACACB (0.83) | ACACB | |
| SCHEMBL15849124 | 0.88 | ACACB (0.83) | ACACB | |
| SCHEMBL15849125 | 0.85 | ACACB (0.77) | ACACB | |
| SCHEMBL9931332 | 0.85 | ACACB (0.67) | ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2794587-B1 | NEW PIPERIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | BOEHRINGER INGELHEIM INT (DE) | 2016-03-16 | — | — | EP | disclosed |
| US-8765959-B2 | Piperidine derivatives | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-07-01 | — | — | US | disclosed |
| US-20130165444-A1 | Piperidine Derivatives | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130165444-A1 | Piperidine Derivatives | PPARD, FABP4, PLIN5 | ACACB 74/4885ACACA 104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.